Infectious complications associated with immunomodulating biologic agents
- PMID: 20466271
- DOI: 10.1016/j.idc.2010.01.006
Infectious complications associated with immunomodulating biologic agents
Abstract
The armamentarium of biologic therapies targeting specific elements of the immune system is rapidly expanding. This review describes the spectrum of infectious complications associated to date with each of the immunomodulating biologic therapies approved by the US Food and Drug Administration.
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Republished in
-
Infectious complications associated with immunomodulating biologic agents.Hematol Oncol Clin North Am. 2011 Feb;25(1):117-38. doi: 10.1016/j.hoc.2010.11.009. Hematol Oncol Clin North Am. 2011. PMID: 21236394
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
